Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05192928 · ClinicalTrials.gov registry record · NA
Feasibility of Ripple Health Smart Pill Caps in Clinical Settings
A NA study of Asthma and Chronic Disease, sponsored by Manan Shukla.
- Completed
- Registry status
- NA
- Development phase
- 16
- Enrollment target
- 4
- Study locations
NCT05192928: Completed NA study of Asthma and Chronic Disease, sponsored by Manan Shukla.
NCT05192928 is a NA study of Asthma and Chronic Disease that has completed, run by Manan Shukla. The registered enrollment target is 16 participants, below the 1,563-participant average among 374 other Asthma trials with a reported enrollment target (99% lower). The trial reports 4 study locations across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05192928, a NA study of Asthma and Chronic Disease, has completed, sponsored by Manan Shukla.
- COMPLETED
- Registry status
- NA
- Development phase
- 16 participants
- Enrollment target
- 4
- Study locations
Study Summary
The purpose of this research is to determine whether Ripple Health Smart Medicine Bottle Caps can allow for better interface medication administration than traditional pill bottles. A secondary goal of the study is to determine whether the smart medication caps can allow the physician to intervene in the patient's health regimen when necessary. This occurs when the patient does not take medication for reasons such as the painful side effects of the medication, or the high cost of the medication itself. By intervening, a physician can therefore help increase patient adherence, and improve transparency between the patient and the physician The bottle cap is in essence a pill bottle that contains circuitry in the cap of the bottle, which sends data to a physician over a wifi network. Once the patient opens the pill bottle, sensors inside the bottle cap will trigger, and send data to the web server indicating that the patient has taken the medication(we are assuming that the patient takes the medication if he/she opens the pill bottle). The server will then add this data into a database that is available to the physician to view. In this study, the proposed use of this pill bottle is as a simple medication container that gets opened when the patient needs to take his/her medication.
Conditions Studied
Interventions
- DEVICE Ripple Health Smart Pill Cap
Study Locations (4)
New York
- Allergy Asthma Sleep Center - Astoria
- Allergy Asthma Sleep Center - Brooklyn
- Allergy Asthma Sleep Center - New York
- Allergy Asthma Sleep Center - Staten Island
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 16 participants |
| Start Date | 2020-07-01 |
| Est. Completion | 2020-08-15 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05192928
The ClinicalTrials.gov registry entry for NCT05192928 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 16 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 1,563-participant average among 374 other Asthma trials with a reported enrollment target (99% lower). The listed sponsor is Manan Shukla, which has 1 total studies on file at ClinicalTrials.gov.
The record links to 2 conditions, with Asthma appearing as the primary indexed condition, and to 1 intervention - of which Ripple Health Smart Pill Cap is the first listed.
NCT05192928 reports 4 study locations spanning 1 distinct geographic area - top geographies include New York.
Frequently Asked Questions
What is clinical trial NCT05192928 about?
NCT05192928 is a clinical study titled "Feasibility of Ripple Health Smart Pill Caps in Clinical Settings". The purpose of this research is to determine whether Ripple Health Smart Medicine Bottle Caps can allow for better interface medication administration than traditional pill bottles. A secondary goal of the study is to determine whether the smart medication caps can allow the physician to intervene i...
What is the current status of trial NCT05192928?
This trial is currently completed. It is a NA study. The enrollment target is 16 participants. The study started on 2020-07-01. Estimated completion is 2020-08-15.
What conditions does trial NCT05192928 study?
This clinical trial studies the following conditions: Asthma, Chronic Disease.
What interventions are being tested in trial NCT05192928?
The interventions under investigation include: Ripple Health Smart Pill Cap (DEVICE).
Who is sponsoring clinical trial NCT05192928?
This trial is sponsored by Manan Shukla, which has 1 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05192928 being conducted?
This trial has 4 study locations across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Asthma
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Automated Inhaler Monitoring for Asthma Medication Usage
RECRUITING · NA
-
Reducing Overuse of Antibiotics With Decision Support
RECRUITING · NA
-
ASTHMAXcel Voice Study
RECRUITING · NA
-
Home Hospital for Suddenly Ill Adults
RECRUITING · NA
-
Asthma and Technology in Emerging African American Adults
RECRUITING · NA
-
BREATHE: An Efficacy-implementation Trial Among Black Adults With Uncontrolled Asthma
RECRUITING · NA
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.